Has Nabil Tariq, MD received payments from drug or device companies?

Yes. Drug and device makers reported $37,145 in general payments to Nabil Tariq, MD across 125 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nabil Tariq, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nabil Tariq, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nabil Tariq, MD

Surgery · Houston, TXNPI 1689881740

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $23,595 of the $37,145 with a category attached, or 63.5%. 27 manufacturers reported payments, led by Johnson & Johnson at 43.3% of the total. 2025 is the largest year on record at $29,506, more than ten times the $198 reported in 2019. Among surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,145in general payments, 2019–2025

Across 125 payments — averaging $297.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$16K
Ethicon Endo-surgery Inc.$8K
Medical Device Business Services, Inc.$4K
Medtronic$2K
Intuitive Surgical$2K
Boston Scientific$2K
plus $2K from 21 others

$12,004in research payments, 2019–2025

Across 1 payment — averaging $12,004 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

TELA Bio, Inc.$12K

What the payments were for

Consulting fees$23,59564%
Travel & lodging$5,94916%
Food & beverage$6,07916%
Education$1,5224%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	15	$16,073
Ethicon Endo-surgery Inc.	1	$8,168
Medical Device Business Services, Inc.	18	$4,254
Medtronic	16	$2,275
Intuitive Surgical	12	$2,063
Boston Scientific	14	$1,894
Davol Inc.	13	$1,163
Novo Nordisk	9	$483
Hologic Sales And Service, LLC	1	$106
Alafair Biosciences, Inc.	2	$79
Dilon Technologies, Inc.	1	$68
Teleflex LLC	2	$55
Baxter Healthcare	1	$47
Vifor Pharma, Inc.	2	$42
Acell, Inc.	1	$42
Integra Lifesciences Corporation	1	$42
Intra-sana Laboratories	3	$36
Currax Pharmaceuticals LLC	2	$35
AstraZeneca	2	$32
Mallinckrodt Hospital Products Inc.	1	$32
Phathom Pharmaceuticals, Inc.	1	$30
Smith+Nephew	2	$26
Pacira Pharmaceuticals Incorporated	1	$22
Eisai Inc.	1	$22
AbbVie	1	$21
TELA Bio, Inc.	1	$20
Tactile Systems Technology Inc	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,145 in reported general payments places this provider in the 90th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$104,399

Medicare patients

135

Services billed

306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	17	$182

Paid to pharmacies, not to this prescriber.

Other surgery in Houston

James SuliburkHouston$161K
Funda MericHouston$141K
Jonathan StahlHouston$105K
Richard KnightHouston$103K
Tanyaradzwa KajeseHouston$92K
Michael HarkinsTomball$2.7M
Douglas StoddardAustin$1.4M
Steven FassAustin$989K
Vineet ChoudhryAustin$851K
Andy HawthorneRound Rock$843K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →